MEME / TRY

MEME / USDT

MEME / USDC

MEME / FDUSD

HYPER / USDT

HYPER / TRY

HYPER / USDC

HYPER / BNB

BIO / FDUSD

BIO / USDC

ASR / TRY

ASR / USDT

ANKR / BTC

AUDIO / BTC

AUDIO / USDT

HIFI / USDT

WBTC / ETH

AUDIO / TRY

TRX / ETH

LRC / ETH

DYNAMIC CABLES LIMITED

ZUARI INDUSTRIES LIMITED

IKIO TECHNOLOGIES LIMITED

KAUSHALYA INFRA DEV LTD.

GRAND CONTINENT HOTELS L

OLA ELECTRIC MOBILITY LTD

ABHA POWER N STEEL LTD

UPSURGE SEEDS OF AGRI LTD

MAHINDRA EPC IRRIG LTD

PROTEAN EGOV TECHNO LTD

NAZARA TECHNOLOGIES LTD

USHA FINANCIAL SERVICES L

HIND RECTIFIER LIMITED

SHIGAN QUANTUM TECH LTD

VARDHMAN POLYTEX LTD.

SHANTHALA FMCG PRODUCTS L

KCK INDUSTRIES LTD

UFLEX LIMITED

DIENSTEN TECH LIMITED

STERLITE TECHNOLOGIES LTD

Click here to get full coverage on A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1  Nature

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

Click here to get full coverage on Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition - Cell Communication and Signaling

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition  Cell Communication and Signaling

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition - Cell Communication and Signaling

Click here to get full coverage on C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer - ScienceDirect.com

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer  ScienceDirect.com

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer - ScienceDirect.com

Click here to get full coverage on European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC  OncLive

European Commission Approves Belzutifan for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Click here to get full coverage on Impact of Linker Composition on VHL PROTAC Cell Permeability - ACS Publications

Impact of Linker Composition on VHL PROTAC Cell Permeability  ACS Publications

Impact of Linker Composition on VHL PROTAC Cell Permeability - ACS Publications

Click here to get full coverage on ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study  UroToday

ASCO 2025: Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitor Belzutifan in Von Hippel-Lindau (VHL) Disease–associated Neoplasms: 5-Year Follow-up of the Phase 2 LITESPARK-004 Study - UroToday

Click here to get full coverage on Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa - JCI.org

Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa  JCI.org

Ablating VHL in rod photoreceptors modulates RPE glycolysis and improves preclinical model of retinitis pigmentosa - JCI.org

Click here to get full coverage on What my sister’s life and death taught me about the NIH - statnews.com

What my sister’s life and death taught me about the NIH  statnews.com

What my sister’s life and death taught me about the NIH - statnews.com

Click here to get full coverage on Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned - PNAS

Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned  PNAS

Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned - PNAS

Click here to get full coverage on Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders  Nature

Drugit: crowd-sourcing molecular design of non-peptidic VHL binders - Nature

Click here to get full coverage on Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study - BioMed Central

Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study  BioMed Central

Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study - BioMed Central

Click here to get full coverage on Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC  OncLive

Belzutifan Displays Robust Activity in VHL-Associated RCC - OncLive

Click here to get full coverage on Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan  UroToday

Belzutifan Demonstrates Durable Activity in VHL Disease Tumors - Vivek Narayan - UroToday

Click here to get full coverage on Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease - Nature

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease  Nature

Loss of VHL-mediated pRb regulation promotes clear cell renal cell carcinoma | Cell Death & Disease - Nature

Click here to get full coverage on Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL) - ACS Publications

Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL)  ACS Publications

Discovery of a Series of Covalent Ligands That Bind to Cys77 of the Von Hippel–Lindau Tumor Suppressor Protein (VHL) - ACS Publications

Click here to get full coverage on Belzutifan Earns Positive CHMP Opinion for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Belzutifan Earns Positive CHMP Opinion for VHL Disease–Associated Tumors, Advanced ccRCC  OncLive

Belzutifan Earns Positive CHMP Opinion for VHL Disease–Associated Tumors, Advanced ccRCC - OncLive

Click here to get full coverage on Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India  Nature

Molecular dynamics reveal potential effects of novel VHL variants on VHL-Elongin C binding in ccRCC patients from Eastern India - Nature

Click here to get full coverage on Stick it with VHL - Nature

Stick it with VHL - Nature

Click here to get full coverage on Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5 - ACS Publications

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5  ACS Publications

Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry Volume 5 - ACS Publications

Click here to get full coverage on Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis - PNAS

Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis  PNAS

Suppressing APOE4-induced neural pathologies by targeting the VHL–HIF axis - PNAS

Click here to get full coverage on Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity - Frontiers

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity  Frontiers

Case Report: A familial hematological pedigree reveals VHL germline mutation as a principal predisposition factor with additional mutations modulating phenotypic heterogeneity - Frontiers

Click here to get full coverage on CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex  Nature

CRISPR-Cas9 genetic screens reveal regulation of TMPRSS2 by the Elongin BC-VHL complex - Nature

Click here to get full coverage on Tough tests against VHL opposition : News | Kontinental Hockey League (KHL) - Официальный сайт КХЛ

Tough tests against VHL opposition : News | Kontinental Hockey League (KHL)  Официальный сайт КХЛ

Tough tests against VHL opposition : News | Kontinental Hockey League (KHL) - Официальный сайт КХЛ

Click here to get full coverage on UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease - UCLA Health

UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease  UCLA Health

UCLA’s multidisciplinary program transforms the outlook for people with von Hippel-Lindau disease - UCLA Health

Click here to get full coverage on Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity - PNAS

Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity  PNAS

Total loss of VHL gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity - PNAS

Click here to get full coverage on The Way Forward for the Virtual Health Library After 27 Years - Pan American Health Organization (PAHO)

The Way Forward for the Virtual Health Library After 27 Years  Pan American Health Organization (PAHO)

The Way Forward for the Virtual Health Library After 27 Years - Pan American Health Organization (PAHO)

Click here to get full coverage on VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway - Nature

VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway  Nature

VHL ameliorates arecoline-induced oral submucosal fibrosis by promoting HDAC6 ubiquitination and blocking NF-κB pathway - Nature

Click here to get full coverage on Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation - ACS Publications

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation  ACS Publications

Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation - ACS Publications

Click here to get full coverage on KRASG12D Selective VHL-PROTAC with sparing KRASWT and Other KRAS Mutants - ScienceDirect.com

KRASG12D Selective VHL-PROTAC with sparing KRASWT and Other KRAS Mutants  ScienceDirect.com

KRASG12D Selective VHL-PROTAC with sparing KRASWT and Other KRAS Mutants - ScienceDirect.com

Click here to get full coverage on Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma - ScienceDirect.com

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma  ScienceDirect.com

Mutations in tumor suppressor genes Vhl and Rassf1a cause DNA damage, chromosomal instability and induce gene expression changes characteristic of clear cell renal cell carcinoma - ScienceDirect.com

Click here to get full coverage on Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design - ACS Publications

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design  ACS Publications

Non-Markovian Dynamic Models Identify Non-Canonical KRAS-VHL Encounter Complex Conformations for Novel PROTAC Design - ACS Publications

Click here to get full coverage on Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC - Nature

Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC  Nature

Inhibition of primary cilia-hedgehog signaling axis triggers autophagic cell death and suppresses malignant progression of VHL wild-type ccRCC - Nature

Click here to get full coverage on Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations - Nature

Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations  Nature

Network modeling links kidney developmental programs and the cancer type-specificity of VHL mutations - Nature

Click here to get full coverage on VHL suppresses the pro-angiogenesis function of tie-2 expression... - researchgate.net

VHL suppresses the pro-angiogenesis function of tie-2 expression...  researchgate.net

VHL suppresses the pro-angiogenesis function of tie-2 expression... - researchgate.net

Click here to get full coverage on Suppression of VHL−/− renal carcinoma proliferation by HIF1α.... - researchgate.net

Suppression of VHL−/− renal carcinoma proliferation by HIF1α....  researchgate.net

Suppression of VHL−/− renal carcinoma proliferation by HIF1α.... - researchgate.net

Click here to get full coverage on VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network - Pan American Health Organization (PAHO)

VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network  Pan American Health Organization (PAHO)

VHL & LILACS - Launch of the 2025 Calendar of Meetings with the MedCarib Network - Pan American Health Organization (PAHO)

Click here to get full coverage on NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs - OncLive

NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs  OncLive

NMPA Approves Belzutifan for VHL in RCC, CNS Hemangioblastomas, or pNETs - OncLive

Click here to get full coverage on Figure 3. VHL inactivation in ccRCC and its implication in targeted... - researchgate.net

Figure 3. VHL inactivation in ccRCC and its implication in targeted...  researchgate.net

Figure 3. VHL inactivation in ccRCC and its implication in targeted... - researchgate.net

Click here to get full coverage on Correction to Supporting Information for Stransky et al., Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned - PNAS

Correction to Supporting Information for Stransky et al., Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned  PNAS

Correction to Supporting Information for Stransky et al., Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned - PNAS

Click here to get full coverage on Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma | Cell Death & Differentiation - Nature

Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma | Cell Death & Differentiation  Nature

Chromosomal 3p loss and 8q gain drive vasculogenic mimicry via HIF-2α and VE-cadherin activation in uveal melanoma | Cell Death & Differentiation - Nature

Click here to get full coverage on Vista Higher Learning Data Breach Impacts an Unknown Number of Consumers - JD Supra

Vista Higher Learning Data Breach Impacts an Unknown Number of Consumers  JD Supra

Vista Higher Learning Data Breach Impacts an Unknown Number of Consumers - JD Supra

Click here to get full coverage on Celebrate Russia Day (Den' Rossii) by Watching VHL Russian League Games on HockeyTV - PRWeb

Celebrate Russia Day (Den' Rossii) by Watching VHL Russian League Games on HockeyTV  PRWeb

Celebrate Russia Day (Den' Rossii) by Watching VHL Russian League Games on HockeyTV - PRWeb

Click here to get full coverage on Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL  National Cancer Institute (.gov)

Belzutifan Approved for Tumors Linked to VHL - National Cancer Institute (.gov)

Click here to get full coverage on The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet? - ScienceDirect.com

The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet?  ScienceDirect.com

The road to systemic therapy in von Hippel-Lindau (VHL) disease: Are we there yet? - ScienceDirect.com

Click here to get full coverage on Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders - ScienceDirect.com

Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders  ScienceDirect.com

Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders - ScienceDirect.com

Click here to get full coverage on Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC - ACS Publications

Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC  ACS Publications

Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC - ACS Publications

Click here to get full coverage on Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles  Nature

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles - Nature

Click here to get full coverage on Figure 1. VHL can be SUMOylated in vitro and in vivo. (A) Schematic... - researchgate.net

Figure 1. VHL can be SUMOylated in vitro and in vivo. (A) Schematic...  researchgate.net

Figure 1. VHL can be SUMOylated in vitro and in vivo. (A) Schematic... - researchgate.net

Click here to get full coverage on Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma  Nature

Tumor heterogeneity in VHL drives metastasis in clear cell renal cell carcinoma - Nature

Click here to get full coverage on VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells - Cell & Bioscience

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells  Cell & Bioscience

VHL Ser65 mutations enhance HIF2α signaling and promote epithelial-mesenchymal transition of renal cancer cells - Cell & Bioscience

Click here to get full coverage on Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - The New England Journal of Medicine

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria  The New England Journal of Medicine

Effects of Germline VHL Deficiency on Growth, Metabolism, and Mitochondria - The New England Journal of Medicine

Click here to get full coverage on Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease  Nature

Critical role of VHL/BICD2/STAT1 axis in crystal-associated kidney disease - Nature

Click here to get full coverage on VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease - Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease  Nature

VHL suppresses UBE3B-mediated breast tumor growth and metastasis | Cell Death & Disease - Nature

Click here to get full coverage on VHL mosaicism: the added value of multi-tissue analysis - Nature

VHL mosaicism: the added value of multi-tissue analysis  Nature

Vardhman Holdings Limited (VHL)

Price Chart

Key Statistics

Technicals

About VHL

Latest News

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1 - Nature

Lactylation modification of HIF-1α enhances its stability by blocking VHL recognition - Cell Communication and Signaling

C-Arg9-APCR3-VHL promotes β-catenin degradation via the VHL-mediated ubiquitin–proteasome system in APC-mutant colorectal cancer - ScienceDirect.com

Advanced Charts

Top Gainers

Top Losers